Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,978 public trials 744 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Snapshot Evaluation of Acute and Chronic Heart Failure in Real Life in Turkey

NCT02578225

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Cukurova University School of Medicine Adana, Turkey (Türkiye)
  • Kocatepe University School of Medicine Afyonkarahisar, Turkey (Türkiye)
  • Hacettepe University School of Medicine Ankara, Turkey (Türkiye)
  • Yüksek İhtisas Training and Research Hospital Ankara, Turkey (Türkiye)
View all 23 locations
View Trial Details
Completed

The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium

NCT01899742

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Medford, Oregon, United States
  • GSK Investigational Site Greenville, South Carolina, United States
  • GSK Investigational Site Spartanburg, South Carolina, United States
  • GSK Investigational Site La Plata, Buenos Aires, Argentina
View all 64 locations
View Trial Details
Completed

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.

NCT01686633

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Newport Beach, California, United States
View all 136 locations
View Trial Details
Completed

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT02105974

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Sunset, Louisiana, United States
  • GSK Investigational Site Saint Charles, Missouri, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
View all 237 locations
View Trial Details
Completed

24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease

NCT01316900

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site DeLand, Florida, United States
  • GSK Investigational Site Orlando, Florida, United States
View all 97 locations
View Trial Details
Completed

Asthma Exacerbation Study

NCT01086384

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Oxford, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 183 locations
View Trial Details
Completed

A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease

NCT02207829

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Spartanburg, South Carolina, United States
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Winnipeg, Manitoba, Canada
View all 99 locations
View Trial Details
Completed

Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT01054885

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Lakewood, California, United States
  • GSK Investigational Site Long Beach, California, United States
View all 149 locations
View Trial Details
Completed

Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

NCT01000506

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 94 locations
View Trial Details

Related conditions